Grey Matters Health raises $1.25 Million to advance Alzheimer’s imaging clinic expansion

Grey Matters Health CEO Christopher Moreau joined Steve Darling from Proactive to discuss the successful completion of the company’s upsized non-brokered private placement and its plans to advance a growing network of specialized neuroimaging clinics focused on Alzheimer’s disease and other neurological disorders. The company announced the closing of the second and final tranche of its financing, raising CAD $750,000 through the issuance of 1,875,000 units at $0.40 per unit. Combined with the first tranche, the financing generated total gross proceeds of CAD $1.25 million. Moreau said the proceeds will be used to advance the company’s Alzheimer’s disease program, support the launch of its first U.S. brain-specific neuroimaging clinics, and provide working capital for ongoing operations. Grey Matters Health is developing a network of specialized NovaScan Neuroimaging Clinics™ that will provide advanced brain PET imaging services for the early detection of Alzheimer’s disease and other forms of dementia, as well as epilepsy, neuro-oncology, and movement disorders such as Parkinson’s disease. The company recently signed a non-binding Letter of Intent with Catalyst MedTech to provide a minimum of 200 brain PET scans for an upcoming Alzheimer’s clinical trial being conducted by an international contract research organization specializing in Alzheimer’s research. The scans are expected to be performed at NovaScan’s planned second location in Tampa, Florida. Grey Matters is also preparing to open its inaugural clinic in Davie, Florida, located within the HCA Florida University Medical Offices building near Fort Lauderdale. Management believes the clinic network will address growing demand for advanced neuroimaging services as healthcare providers increasingly focus on early diagnosis and treatment of neurodegenerative diseases. With financing now completed and clinical partnerships taking shape, the company believes it is well-positioned to advance its U.S. expansion strategy and establish a leading presence in specialized brain imaging services. #proactiveinvestors #greymettershealth #cse #grey #AlzheimersDisease #Neuroimaging #PETScan #HealthcareInnovation #BrainHealth #DementiaResearch #MedicalTechnology #NovaScan #HealthcareServices